Gene · 407014
Papers3,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetics of the Pathogenesis and Complications of Type 2 Diabetes Mellitus. | touchREV Endocrinol | 2023 | 37313245 | PubTator, text mining | PubMed |
| Feeding the gut microbiome: impact on multiple sclerosis. | Front Immunol | 2023 | 37304278 | PubTator, text mining | PubMed |
| The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases-A Review. | Int J Mol Sci | 2023 | 37298095 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression. | Cancers (Basel) | 2023 | 37296932 | PubTator, text mining | PubMed |
| miR-25 promotes cell migration and invasion by inhibiting the expression of CDH1 in rectal carcinoma. | Asian J Surg | 2023 | 37295984 | PubTator, text mining | PubMed |
| Circulating and extracellular vesicle-derived microRNAs as biomarkers in bone-related diseases. | Front Endocrinol (Lausanne) | 2023 | 37293498 | PubTator, text mining | PubMed |
| The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things. | J Transl Med | 2023 | 37286982 | PubTator, text mining | PubMed |
| Small RNA sequencing analysis of peptide-affinity isolated plasma extracellular vesicles distinguishes pancreatic cancer patients from non-affected individuals. | Sci Rep | 2023 | 37286718 | PubTator, text mining | PubMed |
| Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study. | J Neuroinflammation | 2023 | 37264432 | PubTator, text mining | PubMed |
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view. | ESMO Open | 2023 | 37263082 | PubTator, text mining | PubMed |
| Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal. | Pharmaceuticals (Basel) | 2023 | 37259311 | PubTator, text mining | PubMed |
| Comprehensive analysis to construct a novel immune-related prognostic panel in aging-related gastric cancer based on the lncRNA‒miRNA-mRNA ceRNA network. | Front Mol Biosci | 2023 | 37255541 | PubTator, text mining | PubMed |
| miRNAs contributing to the repair of tendon injury. | Cell Tissue Res | 2023 | 37249708 | PubTator, text mining | PubMed |
| p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act. | Nutrients | 2023 | 37242146 | PubTator, text mining | PubMed |
| Application of Polyphenols and Flavonoids in Oncological Therapy. | Molecules | 2023 | 37241819 | PubTator, text mining | PubMed |
| Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis. | Int J Mol Sci | 2023 | 37240338 | PubTator, text mining | PubMed |
| Dynamic Role of Exosome microRNAs in Cancer Cell Signaling and Their Emerging Role as Noninvasive Biomarkers. | Biology (Basel) | 2023 | 37237523 | PubTator, text mining | PubMed |
| Role of the proline-rich disordered domain of DROSHA in intronic microRNA processing. | Genes Dev | 2023 | 37236670 | PubTator, text mining | PubMed |
| Signs and signals limiting myocardial damage using PICSO: a scoping review decoding paradigm shifts toward a new encounter. | Front Cardiovasc Med | 2023 | 37229230 | PubTator, text mining | PubMed |
| N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis. | Genes Dis | 2023 | 37223505 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407014/papers?page=13